GSK (GSK) Shares Up Significantly Since Jim Cramer Said to Buy it “and Put it Away”

Pharma giant GSK (NYSE:GSK) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks.

Pharma giant GSK (NYSE:GSK) made a move to enter the weight loss market earlier this year after it announced that it would acquire 35Pharma and bolster its portfolio to include the HS235 drug that can be used for fat-selective weight loss and muscle mass preservation. Its shares are up by 38% over the past year and by a similar percentage since Cramer discussed the firm in March 2025. GSK (NYSE:GSK) ‘s stock closed 7.3% higher on February 4th, 2026, after the firm reported its fourth quarter earnings report. The results saw the firm post 8.6 billion pounds in revenue and 25.5 pence in earnings to beat analyst estimates. On October 29th, 2025, GSK (NYSE:GSK) ‘s shares closed 5% higher after the firm’s third-quarter earnings saw it raise its 2025 revenue growth estimates to a 6% to 7% from an earlier 3% to 5%. It posted 8.6 billion pounds in revenue and 55 pence on earnings per share to also beat estimates. Here is what Cramer said about the firm a year back:

“Not at all, not at all. I like GSK very much. I think it’s a very good company. I think Dame Walmsley’s doing a terrific job. I think the stock, the fact that it’s at a very low PE and it yields 4%, that’s my kind of stock. I think you put it away, buy it, and put it away.”

GSK (GSK) Shares Up Significantly Since Jim Cramer Said to Buy it "and Put it Away"

While we acknowledge the risk and potential of GSK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than GSK and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.